Patient characteristics and toxicity of the combined cohorts.
tumor, DLTs
TUMOR, METASTASES
In the combined cohort, which included the large tumor expansion cohort plus the original study cohort, 117 patients with 275 metastases were enrolled and started SBRT. Baseline characteristics are shown in There was a total of 7 DLTs for an overall rate of 7.2%. All DLTs occurred in patients who were considered analyzable. 6 DLTs occurred in those that received only complete-Rx (6 of 51, 11.8%) and 1 DLT (1 of 46, 2.2%) in a patient that received partial-Rx (